SEC Form 4 · accession 0001209191-16-133764
Patheon N.V. · PTHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Francisco R. Negron
Officer — President, Drug Product Svcs
Period of report
Jul 20, 2016
Accepted (ET)
Jul 22, 2016 · 5:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001643848
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (Ordinary Shares)F1 | Jul 20, 2016 | A | 261,322 | $0.00 | A | 261,322 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The restricted stock units vest in four equal installments on each anniversary of July 26, 2016, but do not settle in ordinary shares until the occurrence of qualifying exit event and are subject to certain additional performance criteria. Each restricted stock unit represents a contingent right to receive one ordinary share.